Archive.hoparx.org
Guidelines, Standards, and Summaries Resources
WEBThe HOPA Investigational Drug Service Best Practice Standards (PDF) is the first of its kind to provide best practice standards and guidance for pharmacists and institutions to conduct clinical trials. This document emphasizes the critical role of the pharmacy in the investigational drug service, from protocol concept to close-out.
Actived: 6 days ago
URL: http://archive.hoparx.org/resources/guidelines-standards-summaries
Quality Initiatives Volume 19 Issue 3 (2022) HOPA News
WEBDemographics included a population that was 93% white, 5% black, 50% male, and 73% age equal to or greater than age 60. The primary reasons for pharmacist care were treatment with oral anticancer agents (OAA) (52%), non-immunotherapy IV (22%), immunotherapy (20%), and other (7%). A care management code was used to bill 66% …
Volume 19 Issue 1 (2022)
WEBOral oncolytic development has been increasing steadily, making up about 25-35% of the new oncology drug pipeline. 1 With this shift towards oral oncolytic use, many parts of the healthcare system need to evolve to match the pace of this change. While physicians, allied health professionals, and other medical personnel try to keep up with these
Member Spotlight: Alexandra Shillingburg, PharmD BCOP
WEBShillingburg is a clinical pharmacy coordinator at Levine Cancer Institute, Atrium Health, Charlotte, NC, where she specializes in malignant hematology and hematopoietic stem cell transplant in both inpatient and outpatient settings. Early in her career, Dr. Shillingburg developed the role of a clinical pharmacist in the malignant hematology
Barry R. Goldspiel, PharmD BCOP BCPS Fellow of the Hematology
WEBBarry Goldspiel is Acting Chief at the National Institutes of Health Clinical Center Pharmacy Department in Bethesda, Maryland. He received his B.S. in Pharmacy from the Arnold and Marie Schwartz College of Pharmacy in Brooklyn, New York and a Doctor of Pharmacy degree from the University of Texas Health Science Center at San Antonio.
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA Board
WEBLeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, is a Pharmacy Clinical Specialist at Wake Forest Baptist Health (WFBH) in Winston-Salem, NC where she has practiced on the blood and marrow transplant service for 25 years and led the development of the pharmacist-run outpatient transplant program.She is the founding residency director the …
Practice Management Volume 17 Issue 4 (2020) HOPA News
WEBNursing medication administration activities are generally reimbursable in the outpatient setting for IV infusions (96367) and for IV push (96375). 16 2020 Medicare payment rates for those nursing administration codes are estimated at $31.40 and $16.60 respectively. 16.
Volume 17 Issue 3 (2020) HOPA News Membership
WEBHOPA 2019–2020 Publications Committee. Megan Dillaman, PharmD BCOP, Editor Lisa M. Cordes, PharmD BCOP BCACP, Associate Editor Christan M. Thomas, PharmD BCOP, Associate Editor LeAnne Kennedy, PharmD BCOP CPP FHOPA, Board Liaison Jessica Auten, PharmD BCOP BCPS
Lisa M. Holle, PharmD BCOP FHOPA Fellow of the …
WEBLisa M. Holle completed her Bachelor of Science in Pharmacy and post-baccalaureate Doctor of Pharmacy from the University of Wisconsin–Madison. She completed a specialized oncology residency at UT M.D. Anderson Cancer Center, and is a board certified oncology pharmacist. Dr.
Volume 17 Issue 3 (2020)
WEBEstablishing an institutional program for oral anticancer agents allows pharmacists the opportunity to provide patient education and support through a formal process. Three well-established pharmacist-led oral oncology programs are highlighted below. The authors provide insight on the formation and structure of the program, patient flow, and
Clinical Pearls Volume 13 Issue 4 2016 HOPA News Membership
WEBFor treatment of a CNS disease, IT methotrexate is commonly given twice weekly (every 2–5 days) for 4 weeks, then weekly for an additional 4 weeks; once-monthly maintenance dosing may then be administered. 7 For prophylaxis of a CNS disease, the frequency of IT methotrexate varies and is usually dictated by the individual chemotherapy protocol.
Robert Mancini, PharmD BCOP FHOPA Fellow of the …
WEBRobert S. Mancini received his Doctorate of Pharmacy from the University of California, San Diego. He went on to complete a PGY1 residency at St. Luke’s Health System and PGY2 at St. Luke’s Cancer Institute. Dr. Mancini currently serves as the BMT Pharmacy Program Coordinator at St. Luke’s Cancer Institute in Boise, ID and serves as clinical oncology …
HOPA Biosimilars Issue Brief: Improving Access and …
WEB2 current high-cost cancer therapies. HOPA makes the following recommendations to ensure appropriate access to, and safe use of, biosimilars. Support elimination of manufacturer rebate incentives with payers and PBM’s that restrict
Patrick Medina, PharmD BCOP, New At-Large Member for …
WEBFOR IMMEDIATE RELEASE CONTACT Michaella Videka, Marketing Coordinator, HOPA 847.375.4849 | [email protected] Patrick Medina, PharmD BCOP, New At-Large Member for 2019-2020 Term
HOPA Board of Directors Nominations for 2023 Misc …
WEBTHANK YOU to all of the Candidates who expressed their interest in serving during the 2023-2024 Board term. Terms for the above, elected officials begin at the close of HOPA Annual Conference 2023, on April 2, 2023. HOPA supports pharmacy practitioners and seeks to promote and advance hematology/oncology pharmacy to optimize the care of
Top Categories
Popular Searched
› The health insurance specialists trustpilot
› Health and dental insurance nc
› United health care medical pre authorization form
› Primary health chinden and linder
› Health promotion for newborns pdf
› Prohealth dental garden city
› Duke health culture and wellbeing
Recently Searched
› Cedar health research irving tx
› Atrium health medical center plaza
› Walmart healthy food program catalog
› Importance of menstruation in health
› Rural health worker training